In an uncharacteristically quick move, the FDA released this official guidance less than a year after the draft was released for comments. This guidance for medical device manufacturers "recognizes today’s reality – cybersecurity threats are real, ever-present,  and continuously changing."

For more information on the FDA Postmarket Cybersecurity Guidance, see the below post from Dr. Suzanne B. Schwartz

http://blogs.fda.gov/fdavoice/index.php/2016/12/managing-medical-device-cybersecurity-in-the-postmarket-at-the-crossroads-of-cyber-safety-and-advancing-technology/

16 Technology Dr #100

Irvine, CA 92618, USA

1-833-MED-ISAO

1-833-633-4726

contact@medisao.com

© 2020 MediSAO

  • Twitter Icon
  • Black Facebook Icon
  • Black LinkedIn Icon
  • Black YouTube Icon